Hyponatremia after transsphenoidal surgery (TSS) for pituitary tumors occurs in 1.8 to 35% of operated patients [1] [2] [3] [4] [5] [6] . Predicting hyponatremia, especially symptomatic hyponatremia, is useful for providing pertinent care to these patients who may opt for a short post-operative length of hospital stay. In previous studies where the elderly age-bracket (mean: ≥ 50 years), female gender, pre-existing microadenoma, and/or presence of transient diabetes insipidus (DI) were adopted as the predicting factors for hyponatremia [1, 3, 4, [6] [7] [8] [9] , the results were however controversial. These previous papers defined the post-operative hyponatremia simply as post-operative low serum Na, not concerned with the serum Na decline after TSS. Department of Neurosurgery, Onomichi General Hospital, Japan abstract. This study is a retrospective analysis of hyponatremia after transsphenoidal surgery in patients with pituitary adenoma. We evaluated (i) the incidence of post-operative hyponatremia (serum Na levels ≤ 135 mEq/L) and the emergence of hyponatremic symptoms, and assessed (ii) the risk factors under a uniform protocol of i.v. infusion with steroid and electrolyte fluid. We examined 88 consecutive operated patients (female: 60; male: 28) with pituitary adenoma. Apart from reconfirming the effects of the purported risk factors, we focused on the degree of serum Na decline on post-operative hyponatremia. Although remained stable during early post-operative period (4 days after surgery), the serum Na levels subsequently decreased after post-operative day 4 in 81 of 88 cases (92.0%). Of 88 patients, 27 (30.7%) and 9 (10.2%) cases suffered from hyponatremia, and developed hyponatremic symptoms. Interestingly, the degree of serum Na levels decline (from pre-operative levels) indicated a useful independent risk factor for monitoring hyponatremic symptoms (p = 0.006) and the degree of decline tended to be greater in elder patients (> 60 years) (p = 0.0346). Serum Na levels should be monitored from, at least, post-operative day 7 to detect early development of hyponatremia. Special attention and recovery effort should be given to elder patients with marked serum Na level decline after surgery.
Moreover, they did not examine post-operative adrenocortical hormonal replacement in detail.
The development of hyponatremia is certainly influenced by adrenocortical hormone and fluid intake. Variations in post-operative adrenocortical hormonal replacement may affect the post-operative serum Na levels and prolong their effects with a biological halflife of them. Therefore, this study was designed a precise clinical setting; all patients in the cohort underwent a uniform post-operative protocol with i.v. infusion of hormonal replacement and electrolyte fluid, and firstly focused on the degree of serum Na decline after TSS.
Subjects and methods

Patients
The present clinical study was performed with approval of the institutional ethics committee (approval no: 2009-181). We retrospectively studied 91 consecutively operated patients with pituitary adenoma ing to the presence of hyponatremia and hyponatremic symptoms; viz., patients with normonatremia; with hyponatremia but without symptoms; and hyponatremia with symptoms. The monitored factors included age, gender, tumor type, tumor volume, function of ACTHcortisol axis, and transient DI, which reportedly to affect the propensity toward hyponatremia. Transient DI was defined as polyuria of > 600 mL/ 2 h with urine of low specific gravity, and patient requiring antidiuretics. Patients with iatrogenic syndrome of inappropriate secretion of antidiuretic hormone (SIADH) were not found in this study according to appropriate administration of antidiuretics. The tumor volume was calculated as follow: Volume (mm 3 ) = width × height × depth / 2, where the three parameters are measured using 3.0 Tesla magnetic resonance imaging (MRI) unit (GE, Signa Excite). Function of ACTH-cortisol axis was evaluated using a CRH-loading test or an induced hypoglycemia test pre-operatively and in the post-operative 3rd month. Insufficient responses of cortisol who underwent TSS at Hiroshima University Hospital between April 2006 and April 2008. Three patients with ACTH-secreting tumors were excluded from the study because of their singular peri-operative ACTHcortisol secretory dynamics and different dosage requirement for adrenocortical hormone replacement. The remaining 88 cases served as the cohort of this study. The mean age of 28 male (31.8%) and 60 female (68.2%) patients (n = 88) at the time of operation was 47.9 (range: 13-84) years. The particulars of patients are listed in Table 1 . The pituitary functions in all of 88 patients did not change or improved after surgery.
Study design
Serum levels of electrolytes (Na, K, Cl) were measured on immediately before, 1, 4, 7, and during14-28 days after operation. The frequency, onset, and time course of hyponatremia were monitored. Hyponatremia was diagnosed when the serum Na level registered ≤ 135 mEq/L.
Patients were classified into three categories accord- tremia occurred in 27 of 88 (30.7%) patients, with nadir serum Na levels ranged from 120 to 135 (mean: 131.0 ± 3.9) mEq/L (Na 131-135: n = 17; Na ≤ 130: n = 10). Purported risk factors such as age, gender, tumor volume, tumour type, transient DI, or adrenal insufficiency during the pre-and post-operative observation period were not significantly different between the normonatremic and hyponatremic patients (with or without symptoms). Nine of 27 (33.3%) patients with the hyponatremia were symptomatic; complaining of headache (n = 7), nausea (n = 5), vomiting (n = 2), and severe general fatigue (n = 2) in that order from post-operative day 5 to 10 (mean: day 6.5). The serum Na levels in the 9 patients with symptomatic hyponatremia were significantly (p < 0.001) low (127.2 ± 4.1 mEq/L) compared to 133.0 ± 2.0 mEq/L registered in the asymptomatic hyponatremic patients. The serum Na decline in the 9 patients with symptomatic hyponatremia was also significantly (p < 0.001) pronounced (12.9 ± 3.4 mEq/L) compared to 6.4 ± 3.4 mEq/L indicated in the asymptomatic patients.
We then compared the High-decline group (post-TSS serum Na reduction: ≥ 10 mEq/L) with the Lowdecline group (post-TSS serum reduction: < 10 mEq/L) to examine the effects of serum Na variations on the emergence of post-operative hyponatremic symptoms.
From findings on variations of the serum Na levels with time in the High-and Low-decline groups (Fig.  2) , the levels of both groups were rather stable for the first 4 post-operative days. However, the mean serum Na levels subsequently decreased to register 12.5 ± 2.8 and 2.1± 2.8 mEq/L in the High-and Low-decline was defined as the peak values of < 15 μg/dL in the provocation test.
Infusion (i.v.) with steroid replacement and electrolytes
All patients received a uniform adrenocortical hormonal (betamethazone) replacement regimen as follows: 2 mg just before induction of anesthesia, 2 mg on post-operative days 0 and 1, and 1 mg on day 2. Postoperative i.v. infusion was given under a uniform protocol: 1000 mL (0.9% NaCl fluid 500 mL + 0.3% NaCl fluid 500 mL) on post-operative day 0, and 1500 mL (0.9% NaCl fluid 1000 mL + 0.3% NaCl fluid 500 mL) on post-operative day 1. Food intake was started from the morning on post-operative day 1.
Statistical analysis
All statistical analyses were performed using the software package SPSS 16.0 J for Windows (SPSS Inc., IL, USA), and compared using the unpaired two-tailed t-test and Fisher's exact test. Values are expressed as the mean ± standard deviation (SD). Multiple regression analysis was used to estimate the independent effects of predicting variables on the emergence rate of hyponatremic symptoms. Differences where p < 0.05 were considered statistically significant.
results
Although remained stable up to at least post-operative day 4 in all of the three groups (Fig. 1) , the serum Na approached nadir levels on post-operative day 7 in 81 of 88 patients (92.0%). Post-operative hypona- Fig. 1 Changes of the serum Na levels in three groups classified according to their post-operative serum Na levels with or without symptoms: patients who were normonatremia (serum Na levels: > 135mEq/L; ▲, n=61); hyponatremia without symptoms (■, n=18); and hyponatremia with symptoms (•, n=9). Values are expressed as the mean ± SD. The serum Na levels of all groups were stable up to post-operative day 4, and decreased subsequently to register their nadir levels by post-operative day 7. The serum Na level in hyponatremia patients with symptoms was significantly low. Differences where *p < 0.001 between serum Na levels on post-operative day 7 were verified as significant between any 2 of 3 groups, while those where **p < 0.001 between serum Na levels on post-operative days 4 and day 7 were considered as significant for comparisons among the three groups.
different between the two groups. Furthermore, preand post-operative function of the ACTH-cortisol axis were not different, either. However only age showed a tendency leading to decline the post-operative serum Na (p = 0.0578). Then we examined the effects of a factor; old-age (> 60 years) on the secondary hyponagroups on post-operative day 7, respectively ( Table  2 ). The incidence rate of the symptomatic hyponatremia in the High-decline group (61.5%) was significantly higher than 1.3% observed in the Low-decline group. Particulars such as, gender, tumor volume, tumor types, and transient DI were not significantly 28.5±20.0 NS Adrenal insufficiency § 1 (10%) 5 (7.5%) NS Data are expressed as the mean ± SD or n and %. DI: diabetes insipidus; NS: not significant. †Function of ACTHcortisol axis was evaluated by a CRH administration test or an induced hypoglycemia test pre-operatively and in the post-operative 3rd month. §Adrenal insufficiency was defined as cortisol peak <15.0μg/dL. Fig. 2 Changes of the serum Na levels in two groups classified according to the degree of serum Na reduction: Low-decline (< 10 mEq/L; •, n=75); and High-decline (≥ 10 mEq/L; ■, n=13) in serum Na levels. Values are expressed as the mean ± SD. The serum Na levels of both groups were stable until post-operative day 4, however, the serum Na levels in the High-decline group decreased markedly by post-operative day 7. Differences where *p < 0.001 between serum Na levels on post-operative day 7 were considered significant when compared between the two groups.
Discussion
In the present study, we first examined the incidence of time-related hyponatremia after transsphenoidal surgery (TSS), and tried to clarify the risk factors based on consecutive operated patients managed post-operatively with a uniform regimen of corticosteroids and i.v. electrolyte transfusion. Post-operative hyponatremia occurred in 30.7% of patients from postoperative day 4 to 7. Previously reported risk factors influencing post-operative hyponatremia [1, 3, 4, [6] [7] [8] [9] showed insignificant effects in this study. Emergence of hyponatremic symptoms depended on the severity of post-operative hyponatremia, and the degree of post-TSS serum Na reduction. Patients with the serum tremia. Serum Na levels after TSS tended to decrease in elder patients (p = 0.0346), while pre-and post-operative serum Na levels were not significantly different between the elder and younger patients (Table 3) .
When we performed multiple logistic regression analysis of the experimental model to further investigate the factors related to post-TSS symptomatic hyponatremia, age, gender, tumour volume, transient DI, severe post-operative hyponatremia (Na ≤ 130 mEq/L), and marked serum Na decline (post-TSS serum Na reduction: ≥ 10 mEq/L) were found to be relevant but independent factors (Table 4) . Based on these findings, both severe hyponatremia and marked serum Na decline were indicated as independent factors leading to post-TSS hyponatremic symptoms. 
.5%) NS
Data are expressed as the mean ± SD or n and %. TSS, transsphenoidal surgery; NS, not significant. *Hyponatremia was defined as serum Na ≤135 mEq/L. †Function of ACTH-cortisol axis was evaluated by a CRH administration test or an induced hypoglycemia test pre-operatively and in the post-operative 3rd month. §Adrenal insufficiency was defined as cortisol peak <15.0μg/dL. Odds ratio; 95% CI: 95% confidence interval. *Severe hyponatremia was defined as serum Na ≤130 mEq/L after transsphenoidal surgery (TSS); **Marked serum Na decline was defined as Na reduction ≥10 mEq/L after TSS.
lytes and organic osmolytes [14, 15] ; a process which generally requires 48 h [16] . Clinical manifestations of post-operative hyponatremia are, therefore, affected by the rate of hyponatremia development [17] . In other words, it is rational to surmise that a higher degree in post-operative serum Na decline leads to a higher incidence of hyponatremic symptoms in patients within any designated period after TSS.
It is proposed that SIADH is one of the commonest causes of post-operative hyponatremia. Changes in secretory function of natriuretic hormones may play certain roles in the development of hyponatremia [3, 6] , which was probably induced by operative procedure. Therefore, further studies in understanding the dynamics on these hormones in post-TSS condition are warranted to elucidate the exact mechanism(s) that induces hyponatremia. Under a uniform post-operative protocol of adrenocortical hormonal replacement, monitoring intra-and post-operative plasma arginine vasopressin (AVP), a dominant regulator of blood osmolality, may also be constructive in further understanding the mechanisms involved in post-operative hyponatremia.
Conclusions
Previously reported risk factors responsible for induction of hyponatremia after TSS did not show significance influence in managed under a uniform protocol in replacement of adrenal cortical hormone and electrolyte fluid. Emergence of symptoms depended on the degree of post-TSS serum Na decline, and the degree of serum Na decline tended to be greater in elder patients. An abrupt decrease in serum Na level on postoperative day 7 may serve as a harbinger of symptomatic hyponatremia. Therefore, we should manage the post-operative hyponatremia considering the degree of post-TSS serum Na reduction particularly in elder patients with pituitary adenoma. Na decline of ≥ 10 mEq/L were likely to develop postoperative hyponatremic symptoms. Moreover, elder patients (> 60 years) tended to have a greater reduction of serum Na levels after TSS. This discrepancy might have been caused by the different regimen that we have adopted for i.v. infusion of corticosteroid hormone and electrolyte fluid.
Adrenal cortical hormone acts on the distal tubules and collecting ducts of the kidney to enhance reabsorption of Na, thus leading to increases in the serum Na concentration. As the regimen of corticoid replacement (timing and doses) much affects the serum Na concentration, especially betamethazone with a long biological half-life (36-72 hours) [10] , we adopted a uniform protocol in replacement of corticosteroid hormone for our patients after TSS.
Post-TSS hyponatremia (≤ 135 mEq/L) reportedly occurs in 1.8 to 35.0% of patients with serum Na levels registering their nadir levels around post-operative day 7 [1] [2] [3] [4] [5] [6] . Of these patients, 16.7-56.0% [1, 3, 4, 8] who suffered from certain symptoms indicate a mean serum Na level of 120.5-123.5 mEq/L [1, 5, 8, 9] . These results coincide well with our findings in this study. Factors such as old age, microadenoma, transient DI, female, and/or Cushing disease have previously been reported to be risk factors for post-TSS hyponatremia [1] [2] [3] [4] [5] [6] ; however, this hypothesis remain controversial. In this study, these so-called relevant risk factors did not show any significant effects; only the old-age factor showed a tendency (p = 0.0578) leading to post-operative hyponatremia (≤ 135 mEq/L). In respect of the degree of serum Na decline, elder patients (> 60 years) tended to have a greater reduction of serum Na levels after TSS (p = 0.0346).
The age-related decrease in total-body water made elder persons markedly susceptible to stresses on water balance [11] , and the ability of kidney to both conserve Na in response to Na deprivation and to excrete Na in response to Na loading were impaired [12] . Faull et al. showed the ability to excrete a water load was delayed in the elderly [13] . We supposed that the impaired water excretion affected the serum Na levels after TSS easily to decline in elder patients.
This study revealed that patients with a greater reduction of the serum Na level indicated a significantly higher risk of developing symptomatic hyponatremia than patients with a lower reduction range. When the serum Na level abruptly decreases, cells tend to upkeep transmembranous equilibrium by extruding electro-
